H Antretter1, J Dumfarth2, D Höfer2. 1. Universitätsklinik für Herzchirurgie, Department Operative Medizin, Medizinische Universität Innsbruck, Anichstr. 35, 6020, Innsbruck, Österreich. herwig.antretter@i-med.ac.at. 2. Universitätsklinik für Herzchirurgie, Department Operative Medizin, Medizinische Universität Innsbruck, Anichstr. 35, 6020, Innsbruck, Österreich.
Abstract
BACKGROUND: To date the CardioWest™ total artificial heart is the only clinically available implantable biventricular mechanical replacement for irreversible cardiac failure. OBJECTIVES: This article presents the indications, contraindications, implantation procedere and postoperative treatment. MATERIAL AND METHODS: In addition to a overview of the applications of the total artificial heart this article gives a brief presentation of the two patients treated in our department with the CardioWest™. RESULTS: The clinical course, postoperative rehabilitation, device-related complications and control mechanisms are presented. CONCLUSION: The total artificial heart is a reliable implant for treating critically ill patients with irreversible cardiogenic shock. A bridge to transplantation is feasible with excellent results.
BACKGROUND: To date the CardioWest™ total artificial heart is the only clinically available implantable biventricular mechanical replacement for irreversible cardiac failure. OBJECTIVES: This article presents the indications, contraindications, implantation procedere and postoperative treatment. MATERIAL AND METHODS: In addition to a overview of the applications of the total artificial heart this article gives a brief presentation of the two patients treated in our department with the CardioWest™. RESULTS: The clinical course, postoperative rehabilitation, device-related complications and control mechanisms are presented. CONCLUSION: The total artificial heart is a reliable implant for treating critically illpatients with irreversible cardiogenic shock. A bridge to transplantation is feasible with excellent results.
Authors: Josef Stehlik; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Jason D Christie; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2011-10 Impact factor: 10.247
Authors: James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; J Timothy Baldwin; James B Young Journal: J Heart Lung Transplant Date: 2012-02 Impact factor: 10.247
Authors: James K Kirklin; David C Naftel; Francis D Pagani; Robert L Kormos; Lynne W Stevenson; Elizabeth D Blume; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young Journal: J Heart Lung Transplant Date: 2014-04-21 Impact factor: 10.247
Authors: Michael J Bonios; John V Terrovitis; Stavros G Drakos; Fotis Katsaros; Chris Pantsios; Serafim N Nanas; John Kanakakis; George Alexopoulos; Savvas Toumanidis; Maria Anastasiou-Nana; John N Nanas Journal: Int J Cardiol Date: 2011-04-08 Impact factor: 4.164
Authors: Thomas Puehler; Stephan Ensminger; Michael Schoenbrodt; Jochen Börgermann; Erik Rehn; Kavous Hakim-Meibodi; Michiel Morshuis; Jan Gummert Journal: Ann Cardiothorac Surg Date: 2014-09
Authors: Jack G Copeland; Richard G Smith; Francisco A Arabia; Paul E Nolan; Gulshan K Sethi; Pei H Tsau; Douglas McClellan; Marvin J Slepian Journal: N Engl J Med Date: 2004-08-26 Impact factor: 91.245
Authors: J Raymond Fitzpatrick; John R Frederick; Vivian M Hsu; Elliott D Kozin; Mary Lou O'Hara; Elan Howell; Deborah Dougherty; Ryan C McCormick; Carine A Laporte; Jeffrey E Cohen; Kevin W Southerland; Jessica L Howard; Mariell L Jessup; Rohinton J Morris; Michael A Acker; Y Joseph Woo Journal: J Heart Lung Transplant Date: 2008-12 Impact factor: 10.247
Authors: Jean Christian Roussel; Thomas Sénage; Olivier Baron; Christian Périgaud; Oussama Habash; Jean Christophe Rigal; Michèle Treilhaud; Jean Noel Trochu; Philippe Despins; Daniel Duveau Journal: Ann Thorac Surg Date: 2009-01 Impact factor: 4.330